Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group Practice
Author(s): Presti J; Alexeeff S; Horton B; Prausnitz S; Avins AL
J Gen Intern Med. 2019 Dec 09.
PubMed abstractThe Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing
Author(s): Eklund M; StLezin M; Grönberg H; et al.
Eur Urol Focus. 2018 09;4(5):707-710. Epub 2016-11-23.
PubMed abstractA Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease
Author(s): Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol. 2018 01;73(1):129-138. Epub 2017-10-06.
PubMed abstract